Senator Dianne Feinstein (D-CA) and consumer advocacy groups such as Safer Chemicals, Healthy Families took part in the Society’s Twitter chat on endocrine-disrupting chemicals and personal care products Wednesday. The conversation was the Society’s largest Twitter chat to date. Moderated by member Jodi Flaws, PhD, and Society staff, the event hashtag was viewed more than...
The Society and members of the Obesity Care Action Network conducted educational briefings at both the Republican and Democratic Conventions to educate policymakers about obesity, change mindsets, and increase support for access to evidence-based obesity care. Through these efforts, the goal is to make more members of Congress aware of and support the Treat and...
2016 is a landmark year for the endocrine disruption (EDC) field. This year is the 25th anniversary of the Wingspread Conference on environmental endocrine disruption, the 50th anniversary of environmental health research at the National Institutes of Health (NIH), and the 100th anniversary of the Endocrine Society. It is also the 20th anniversary of Our...
On July 14, the House Appropriations Committee approved its fiscal year (FY) 2017 Labor, Health and Human Services (LHHS), Education and Related Agencies Appropriations spending measure which includes funding for the National Institutes of Health (NIH). The House LHHS bill provides an additional $1.25 billion for biomedical research, which would raise the NIH budget to...
On May 18, the Endocrine Society attended the 201st meeting of the National Diabetes and Digestive and Kidney Diseases (NIDDK) Advisory Council. Society members Lee Kaplan, MD, PhD, Alan Saltiel, PhD, and Joel Elmquist, PhD, DVM, are members of the NIDDK Council, which advises the director of the NIDDK on research, support activities, and functions...
On June 9, the Senate Appropriations Committee approved the fiscal year (FY) 2017 Labor, Health and Human Services (LHHS) Appropriations bill by a vote of 29-1 (James Lankford [R-OK] was the only “no” vote). The bill provides a $2 billion increase for the National Institutes of Health (NIH), bringing the agency’s budget to $34.1 billion...
The Endocrine Society expressed disappointment and concern today that the European Commission’s regulatory criteria are too strict to effectively protect the public from endocrine-disrupting chemicals (EDCs). “The European Commission has set the bar so high that it will be challenging for chemicals to meet the standard, even when there is scientific evidence of harm,” said...
On May 6, Endocrine Society members Richard Legro, MD, and Carole Mendelson, PhD, represented the Society at a meeting with leadership from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), including the Acting Director of the NICHD, Catherine Spong, MD. During the meeting, Legro and Mendelson discussed how to maintain...
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.